BLISSGVSBSEBliss GVS Pharma LtdMediumNeutral
Announced Mon, 25 May · 19:03 IST

Intimation of Completion of Term of Mr. Santosh Parab (DIN: 01622988) as an Independent Director of the Company.

Management Changes View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+24.8%1-day move
₹318.00
prior close
₹321.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+5.2+10.4+9.9+16.6+24.8+33.5+26.5+37.1+38.1+37.6+50.0+67.0+43.6
Up moveDown movePending
AI summary

Mr. Santosh Parab has completed his second and final term as an Independent Director of Bliss GVS Pharma Ltd. He served two consecutive 5-year terms (from May 26, 2021 to May 25, 2026) on the board. With this completion, he has ceased to be a Director and member of all Committees of the Company effective close of business hours on May 25, 2026. The Company has expressed gratitude for his valuable contribution during his tenure. This is a routine governance event as Independent Directors are permitted a maximum tenure of two terms under the Companies Act.

Likely market impact

This is a standard term completion for an Independent Director reaching the maximum permitted tenure. No immediate impact on operations is expected, but shareholders should note the change in board composition.